A common question from chemical and composite manufacturers is whether resin formulation development can qualify as research and development for the federal R&D tax credit under Section 41. The short answer is that resin formulation development may constitute qualified research when the work evaluates alternative formulations to resolve a technical uncertainty about resin performance. Routine resin compounding using established recipes generally is not qualified research. This page explains the framework in general terms. It is educational and is not individualized advice. For the foundational framework, see our page on qualified research.
When Resin Development May Warrant Review
Resin formulation development may warrant review when the work involves a genuine technical uncertainty and a process of experimentation. Under the four-part test, the work must be for a permitted purpose, be technological in nature (relying on chemistry), be intended to eliminate uncertainty, and be conducted through a process of experimentation.
Common scenarios that may warrant review include:
- New resin — evaluating alternative resin formulations to resolve uncertainty about whether a new resin can achieve the required properties.
- New hardener — testing alternative hardeners to resolve uncertainty about whether a new hardener can achieve the required cure performance.
- New application — evaluating alternative formulations to resolve uncertainty about whether a resin can be used in a new application.
- Property target — testing alternative formulations to resolve uncertainty about what properties a new resin can achieve.
Routine Compounding vs. Development
A central distinction is between routine resin compounding and resin development:
- Routine compounding — compounding a resin using an established recipe. There is no technical uncertainty. This is compounding, not research.
- Development — developing a new resin formulation where there is a technical uncertainty about whether the formulation can achieve the required performance, and evaluating alternatives to resolve that uncertainty. This may warrant review.
Hypothetical Example
Consider a manufacturer that is developing a new resin formulation for a high-performance composite and is uncertain whether any available formulation can achieve the required strength and temperature resistance. The company evaluates alternative formulations, tests each, and systematically varies the approach to resolve the uncertainty. This systematic evaluation of alternatives may warrant review as qualified research.
By contrast, if the same manufacturer compounds a standard resin using an established recipe, that is routine compounding, not research.
This example is illustrative only and does not state that the activity definitely qualifies.
Documentation That May Help
Records that can help support resin development claims include development records identifying the uncertainty and alternative formulations, property test results, and records of how results informed formulation changes. For more, see our page on R&D tax credit documentation.
Key Takeaway
Resin formulation development may constitute qualified research when the work evaluates alternative formulations to resolve a technical uncertainty about resin performance. Routine resin compounding using established recipes generally is not qualified research. Because the distinction is fact-specific, professional review is appropriate before claiming the credit.